Drugs that contain Besifloxacin Hydrochloride

1. Drug name - BESIVANCE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8481526 BAUSCH AND LOMB Fluoroquinolone carboxylic acid molecular crystals
Jan, 2031

(8 years from now)

CN102369189B BAUSCH AND LOMB Fluoroquinolone Carboxylic Acid Molecular Crystals
Mar, 2030

(7 years from now)

CN102369189A BAUSCH AND LOMB Fluoroquinolone Carboxylic Acid Molecule Crystal
Mar, 2030

(7 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8937062 BAUSCH AND LOMB Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria Nov, 2029

(7 years from now)

US8604020 BAUSCH AND LOMB Fluoroquinolone carboxylic acid molecular crystals Mar, 2030

(7 years from now)

US8415342 BAUSCH AND LOMB Besifloxacin ophthalmic composition for the treatment or control of infection Nov, 2030

(8 years from now)

Treatment: Method of treating ocular bacterial infections

Dosage: SUSPENSION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
EQ 0.6% BASE SUSPENSION/DROPS;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.